Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
myo-inositol + d-chiro-inositol
- Development stage
- Phase 1
- Lead developer
- DMC Biotechnologies
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Myo-inositol + d-chiro-inositol is a combination of two stereoisomers of inositol—myo-inositol (MI) and d-chiro-inositol (DCI)—commonly used as a dietary supplement. Both compounds are involved in insulin signaling pathways but act on different cellular processes. The combination is most often administered in a physiological plasma ratio of 40:1 (MI to DCI). This blend has been shown to improve metabolic parameters, enhance ovarian function, and support hormone balance—especially in women with polycystic ovary syndrome (PCOS), where it can reduce insulin resistance and hyperinsulinemia. It also shows benefits for glycemic control in type 2 diabetes mellitus (T2DM). The mechanism involves improving insulin sensitivity at the cellular level, supporting ovarian health by modulating androgen production and ovulation, and contributing to overall reproductive health[1][4][7][10]. The combination is generally well-tolerated with minimal side effects at recommended doses.
- Brand names
- Inofolic AlphaPlusMyo & D-Chiro InositolMyo-Inositol & D-Chiro Inositol
- Other names
- myo-inositol and d-chiro-inositolMI + DCI
Beyond the preview
Go deeper on myo-inositol + d-chiro-inositol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on myo-inositol + d-chiro-inositol.